National Football League Calls for Ban on Certain Prediction Market Contracts Citing Integrity Concerns ReadytoDrink Cocktails Positioned as Alcohol Industrys Growth Engine for 2026 Alain Prost Injured in Home Raid Near Geneva Security Implications for HighProfile Figures Rising Costs Drive UnRetirement Trend as Older Americans Rejoin Workforce Palantir Accuses London Mayor Sadiq Khan of Politicizing Procurement After 50m Met Police Contract Blocked Kingfisher Shares Rise as BQ Weathers Easter Sales Dip Eyes Heatwave Recovery JBGS Q1 2026 Earnings Positive EPS Amidst Modest Market Reaction GGAL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Argentine Macro Environment DCTH Q1 2026 Earnings NarrowerThanExpected Loss Bolstered by Cost Discipline AZN Q1 2026 Earnings EPS Misses Estimates by 05 Stock Declines 14 SDRL Q1 2026 Earnings NarrowerthanExpected Loss Boosts Surprise but Shares Slip DTM Q1 2026 Earnings EPS Surpasses Expectations by Nearly 10 Stock Edges Lower Gabelli Utility Trust GUT Edges Higher in Quiet Session Eaton Vance Global Dividend Income Fund ETG Holds Steady as YieldSeekers Maintain Support Cheche Group Warrant Slips Further CCGWW Hovers at 002 Amid Thin Trading Victorias Secret Co VSCO Gains 42 as Retail Sector Shows Resilience Global Self Storage Inc SELF Modestly Advances as Shares Test Key Support Level IRFC Secures 13527 Crore Refinancing Deal for Hyderabad Metro Expansion RDNW Q1 2026 Earnings NarrowerThanExpected Loss Exceeds Analyst Estimates TPG Mortgage Investment Trust Senior Notes MITP Consolidating Near 2520 After Slight Decline CHRS Q1 2026 Earnings EPS Surpasses Estimates Despite Net Loss Stock Edges Lower PZG Q1 2026 Earnings Significant EPS Miss Reflects PreRevenue Exploration Stage NGNE Q1 2026 Earnings Earnings Miss Estimates as Pipeline Progress Offsets Financial Headwinds NRX Pharmaceuticals Inc Q1 2026 Earnings EPS Misses Estimates Stock Declines James Hardie Industries JHX Q1 2026 Earnings EPS Misses Estimates Amid Sluggish Demand MLYS Q1 2026 Earnings Narrow Beat on Losses as Clinical Pipeline Progress Continues FFWM Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises